Birner Dental Management Services, Inc. Announces Results For 3Q 2017
DENVER, Nov. 14, 2017 /PRNewswire/ -- Birner Dental Management Services, Inc. (OTCQX: BDMS), business services provider of PERFECT TEETH® dental practices, announced results for the quarter and nine months ended September 30, 2017. For the quarter ended September 30, 2017, revenue increased $390,000, or 2.6% to $15.5 million. The Company's earnings before interest, taxes, depreciation, amortization, stock grant, and stock-based compensation expense ("Adjusted EBITDA") decreased $104,000, or 31.1% to $231,000 for the quarter ended September 30, 2017. Net loss for the quarter ended September 30, 2017 increased $41,000 to $(558,000) compared to $(517,000) for the quarter ended September 30, 2016. Net loss per share increased to $(0.30) for the quarter ended September 30, 2017 compared to $(0.28) for the quarter ended September 30, 2016.
The Company believes it is in the initial stages of turning its operations around, including increasing its dentist count and revenue. As indicated above, revenue increased 2.6% in the third quarter of 2017 versus the same quarter in 2016 and also increased 5.2% or $765,000 from the second quarter of 2017. Additionally, the Company experienced a progressively increasing daily same store sales rate in the third quarter of 2017, culminating in September's daily same store sales up 6.5% versus September 2016. This trend has continued through October 2017. These results are directly related to increases in the Company's dentist count as more fully disclosed below. New patient visits were up 6.2% in the quarter ended September 30, 2017 versus the same quarter in 2016. As dentist count increases, management believes operating results will improve through increased revenue and Adjusted EBITDA.
While the Company was disappointed in the net loss generated in the third quarter of 2017, it has made certain cost reduction efforts to address this issue. These efforts, which commenced mid-September 2017, include suspension of certain bonus programs and the Company's contribution to the 401(k) plan along with elimination of certain support personnel in dental offices.
For the nine months ended September 30, 2017, revenue decreased $1.5 million, or 3.1%, to $46.0 million. The Company's Adjusted EBITDA decreased $1.3 million, or 60.0%, to $862,000 for the nine months ended September 30, 2017. Net loss for the nine months ended September 30, 2017 increased $837,000 to $(1.7 million) compared to $(847,000) for the nine months ended September 30, 2016. Net loss per share increased to $(0.90) for the nine months ended September 30, 2017 compared to $(0.46) for the nine months ended September 30, 2016. The Company incurred additional expenses of approximately $396,000 during the nine months ended September 30, 2017 in connection with matters related to the activist shareholder group and the Board of Directors' evaluation of the Company's strategic options.
As previously reported, the Company believes much of the decline in revenue and Adjusted EBITDA for the nine months ended September 30, 2017 was driven by lower dentist counts relative to the same period a year ago. Since June 30, 2017, the Company's dentist count has increased and at September 30, 2017 was 106. The Company believes it has now achieved more stability in its affiliated dentists and should continue to experience an increase in its dentist count in the future.
During the nine months ended September 30, 2017, the Company had capital expenditures of $521,000 and decreased total bank debt outstanding by approximately $1.1 million.
As previously disclosed in a Form 8-K filed in July 2017 with the Securities and Exchange Commission and in the Company's second quarter Form 10-Q, on July 21, 2017 the Company received notice of events of default and acceleration from its bank in connection with its bank credit agreements. The notice asserted events of default resulting from the Company's failure to produce EBITDA of at least $870,000 for the second quarter of 2017 and to reduce the outstanding balance on the reducing revolving loan by at least $500,000 on June 30, 2017. The Company also failed to reduce the dollar amount of the outstanding reducing revolver by at least $500,000 on September 30, 2017. The Company's revolving line of credit with the Bank was reduced from $1.4 million to $1.1 million on October 1, 2017 as required by the March 2017 amendment and forbearance agreement. As of September 30, 2017, $8.8 million was outstanding under the credit facility.
In the notice, the bank declared all obligations of the Company to be immediately due and payable and demanded payment in full of all obligations by no later than July 31, 2017. The notice further stated that, although the bank is not presently exercising its other rights and remedies available upon an event of default, it reserves its right to do so at any time in its sole discretion.
The Company has been engaged in discussions with the bank regarding a resolution of this matter. The Company believes that any resolution with the bank would involve financing to raise funds to pay down the outstanding principal on the credit facility or to refinance the credit facility. The Company has held discussions with several potential investors and lenders and has explored several funding options, including the issuance of additional equity or debt and the sale of certain dental practices. The Company has signed a term sheet with a prospective investor and is currently negotiating definitive agreements with that party on an exclusive basis and with the bank for amendments to the credit facility. There is no assurance that these transactions will be completed.
Birner Dental Management Services, Inc. acquires, develops, and manages geographically dense dental practice networks in select markets in Colorado, New Mexico, and Arizona. As of September 30, 2017, the Company managed 68 dental offices, of which 35 were acquired and 33 were de novo developments. The Company operates its dental offices under the PERFECT TEETH® name.
The Company previously announced it would conduct a conference call to review results for the quarter ended September 30, 2017 on Tuesday, November 14, 2017 at 9:00 a.m. MT. In addition to current operating results, the teleconference may include discussion of management's expectations of future financial and operating results. To participate in this conference call, dial in to 1-877-718-5106 and refer to Confirmation Code 6218016 approximately five minutes prior to the scheduled time. If you are unable to join the conference call on November 14, 2017, the rebroadcast number is 1-888-203-1112 with Passcode 6218016. This rebroadcast will be available through November 28, 2017.
Non-GAAP Disclosures
This press release includes a non-GAAP financial measure with respect to Adjusted EBITDA. Please see below for more information regarding Adjusted EBITDA and a reconciliation of Adjusted EBITDA to net loss.
Forward-Looking Statements
Certain of the matters discussed herein may contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from expectations. These include statements regarding the Company's prospects and performance in future periods, including improvement in operating results, revenue and Adjusted EBITDA, dentist hiring, the amount of bank debt, compliance with debt covenants and actions by the Company's lender, negotiation of financing arrangements and amendments to the Company's credit agreements, dentist count, dentist turnover and recruitment, dentist productivity, new patient visits and patient flow and the impact of certain shareholder matters. These statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These and other risks and uncertainties are set forth in the reports filed by the Company with the Securities and Exchange Commission, including the Company's Form 10-K for the year ended December 31, 2016. The Company disclaims any obligation to update these forward-looking statements.
For Further Information Contact:
Birner Dental Management Services, Inc.
Dennis Genty
Chief Financial Officer
(303) 691-0680
BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES |
|||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||
(UNAUDITED) |
|||||||||
Quarters Ended |
Nine Months Ended |
||||||||
September 30, |
September 30, |
||||||||
2016 |
2017 |
2016 |
2017 |
||||||
REVENUE: |
|||||||||
Dental practice revenue |
$ 13,988,133 |
$ 14,542,690 |
$ 44,009,444 |
$ 42,915,170 |
|||||
Capitation revenue |
1,166,155 |
1,001,297 |
3,461,218 |
3,068,716 |
|||||
15,154,288 |
15,543,987 |
47,470,662 |
45,983,886 |
||||||
DIRECT EXPENSES: |
|||||||||
Clinical salaries and benefits |
9,242,477 |
9,680,390 |
28,564,107 |
28,398,877 |
|||||
Dental supplies |
729,299 |
674,402 |
2,187,229 |
1,974,995 |
|||||
Laboratory fees |
869,014 |
874,102 |
2,648,658 |
2,687,004 |
|||||
Occupancy |
1,591,841 |
1,637,622 |
4,712,445 |
4,840,771 |
|||||
Advertising and marketing |
176,150 |
148,257 |
490,227 |
485,628 |
|||||
Depreciation and amortization |
988,031 |
869,589 |
3,026,164 |
2,748,083 |
|||||
General and administrative |
1,394,284 |
1,464,120 |
4,139,482 |
4,014,757 |
|||||
14,991,096 |
15,348,482 |
45,768,312 |
45,150,115 |
||||||
Contribution from dental offices |
163,192 |
195,505 |
1,702,350 |
833,771 |
|||||
CORPORATE EXPENSES: |
|||||||||
General and administrative |
848,358 |
(1) |
908,267 |
(1) |
2,696,123 |
(2) |
2,879,641 |
(2) |
|
Stock grant |
- |
- |
- |
175,000 |
(3) |
||||
Depreciation and amortization |
47,114 |
38,518 |
165,994 |
123,466 |
|||||
OPERATING LOSS |
(732,280) |
(751,280) |
(1,159,767) |
(2,344,336) |
|||||
OTHER EXPENSE: |
|||||||||
Interest expense, net |
70,367 |
110,004 |
185,240 |
276,842 |
|||||
LOSS BEFORE INCOME TAXES |
(802,647) |
(861,284) |
(1,345,007) |
(2,621,178) |
|||||
Income tax benefit |
(286,131) |
(303,719) |
(497,653) |
(937,281) |
|||||
NET LOSS |
$ (516,516) |
$ (557,565) |
$ (847,354) |
$ (1,683,897) |
|||||
Net loss per share of Common Stock - Basic |
$ (0.28) |
$ (0.30) |
$ (0.46) |
$ (0.90) |
|||||
Net loss per share of Common Stock - Diluted |
$ (0.28) |
$ (0.30) |
$ (0.46) |
$ (0.90) |
|||||
Weighted average number of shares of |
|||||||||
Common Stock and dilutive securities: |
|||||||||
Basic |
1,860,261 |
1,872,761 |
1,860,334 |
1,866,580 |
|||||
Diluted |
1,860,261 |
1,872,761 |
1,860,334 |
1,866,580 |
(1) |
Corporate expense - general and administrative includes $32,309 and $74,031 of stock-based compensation expense pursuant to ASC Topic 718 for the quarters ended September 30, 2016 and 2017, respectively. |
||||||||
(2) |
Corporate expense - general and administrative includes $123,118 and $160,286 of stock-based compensation expense pursuant to ASC Topic 718 for the nine months ended September 30, 2016 and 2017, respectively. |
||||||||
(3) |
The Company issued 12,500 shares of Common Stock under a settlement agreement with an activist shareholder group. The shares were valued at $175,000 based on the closing price of the Common Stock on the date of the grant. |
BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES |
||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||
(UNAUDITED) |
||||
December 31, |
September 30, |
|||
ASSETS |
2016 |
2017 |
||
CURRENT ASSETS: |
||||
Cash |
$ 157,923 |
$ 239,545 |
||
Accounts receivable, net of allowance for doubtful |
||||
accounts of approximately $410,000 and $430,000, respectively |
3,212,190 |
4,011,911 |
||
Note receivable |
34,195 |
34,195 |
||
Prepaid expenses and other assets |
759,749 |
749,742 |
||
Total current assets |
4,164,057 |
5,035,393 |
||
PROPERTY AND EQUIPMENT, net |
7,279,436 |
5,562,629 |
||
OTHER NONCURRENT ASSETS: |
||||
Intangible assets, net |
6,721,084 |
6,087,194 |
||
Deferred charges and other assets |
155,741 |
163,991 |
||
Note receivable |
31,051 |
7,620 |
||
Total assets |
$ 18,351,369 |
$ 16,856,827 |
||
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) |
||||
CURRENT LIABILITIES: |
||||
Accounts payable |
$ 2,723,473 |
$ 4,349,373 |
||
Accrued expenses |
925,776 |
803,513 |
||
Accrued payroll and related expenses |
2,164,758 |
2,522,354 |
||
Current maturities of long-term debt |
2,500,000 |
8,757,469 |
||
Total current liabilities |
8,314,007 |
16,432,709 |
||
LONG-TERM LIABILITIES: |
||||
Deferred tax liability, net |
1,174,416 |
284,128 |
||
Long-term debt |
7,351,006 |
- |
||
Other long-term obligations |
1,081,655 |
1,058,316 |
||
Total liabilities |
17,921,084 |
17,775,153 |
||
SHAREHOLDERS' EQUITY (DEFICIT): |
||||
Preferred Stock, no par value, 10,000,000 shares |
||||
authorized; none outstanding |
- |
- |
||
Common Stock, no par value, 20,000,000 shares |
||||
authorized; 1,860,261 and 1,872,761 shares issued and |
||||
outstanding, respectively |
1,615,001 |
1,950,287 |
||
Accumulated deficit |
(1,184,716) |
(2,868,613) |
||
Total shareholders' equity (deficit) |
430,285 |
(918,326) |
||
Total liabilities and shareholders' equity (deficit) |
$ 18,351,369 |
$ 16,856,827 |
||
Reconciliation of Adjusted EBITDA
Adjusted EBITDA is not a U.S. generally accepted accounting principle ("GAAP") measure of performance or liquidity. However, the Company believes that it may be useful to an investor in evaluating the Company's ability to meet future debt service, capital expenditures and working capital requirements, and the Company uses Adjusted EBITDA for this purpose. Investors should not consider Adjusted EBITDA in isolation or as a substitute for operating income, cash flows from operating activities or any other measure for determining the Company's operating performance or liquidity that is calculated in accordance with GAAP. In addition, because Adjusted EBITDA is not calculated in accordance with GAAP, it may not necessarily be comparable to similarly titled measures employed by other companies. A reconciliation of Adjusted EBITDA to net loss can be made by adding depreciation and amortization expense - Offices, depreciation and amortization expense – Corporate, stock-based compensation expense, interest expense, net, stock grant expense and income tax (benefit) to net loss as in the table below.
Quarters |
Nine Months |
|||||||||
Ended September 30, |
Ended September 30, |
|||||||||
2016 |
2017 |
2016 |
2017 |
|||||||
RECONCILIATION OF ADJUSTED EBITDA: |
||||||||||
Net loss |
($516,516) |
($557,565) |
($847,354) |
($1,683,897) |
||||||
Add back: |
||||||||||
Depreciation and amortization - Offices |
988,031 |
869,589 |
3,026,164 |
2,748,083 |
||||||
Depreciation and amortization - Corporate |
47,114 |
38,518 |
165,994 |
123,466 |
||||||
Stock-based compensation expense |
32,309 |
74,031 |
123,118 |
160,286 |
||||||
Interest expense, net |
70,367 |
110,004 |
185,240 |
276,842 |
||||||
Stock grant |
- |
- |
- |
175,000 |
||||||
Income tax benefit |
(286,131) |
(303,719) |
(497,653) |
(937,281) |
||||||
Adjusted EBITDA |
335,174 |
$230,858 |
$2,155,509 |
$862,499 |
||||||
SOURCE Birner Dental Management Services, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article